Trial Profile
A Phase 4, Open-Label, Single-Group Safety and Immunogenicity Study of RECOTHROM (rThrombin) in Pediatric Subjects Undergoing Synchronous Burn Wound Excision and Skin Grafting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Thrombin alfa (Primary)
- Indications Surgical blood loss
- Focus Adverse reactions; Therapeutic Use
- Sponsors ZymoGenetics
- 28 May 2014 New trial record